000 | 00960 a2200265 4500 | ||
---|---|---|---|
005 | 20250515164722.0 | ||
264 | 0 | _c20091208 | |
008 | 200912s 0 0 eng d | ||
022 | _a1537-453X | ||
024 | 7 |
_a10.1097/COC.0b013e318172dccd _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSonpavde, Guru | |
245 | 0 | 0 |
_aPatient selection for phase II trials. _h[electronic resource] |
260 |
_bAmerican journal of clinical oncology _cApr 2009 |
||
300 |
_a216-9 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
650 | 0 | 4 | _aClinical Trials, Phase II as Topic |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aPatient Selection |
700 | 1 | _aGalsky, Matthew D | |
700 | 1 | _aHutson, Thomas E | |
700 | 1 | _aVon Hoff, Daniel D | |
773 | 0 |
_tAmerican journal of clinical oncology _gvol. 32 _gno. 2 _gp. 216-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1097/COC.0b013e318172dccd _zAvailable from publisher's website |
999 |
_c18781980 _d18781980 |